Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
59 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00083486 | Treatment of Anemia in Patients With Cancer Who Are Not Currently Receiving Chemotherapy or Radiotherapy | terminated | Phase 3 | — | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 1 | Apr 27, 2011 | clinicaltrials |
| NCT00354146 | A Phase 2 Study of Farnesyl Transferase Inhibitor (R115777, Tipifarnib) in Patients With Refractory or Relapsed Acute Myeloid Leukemia. | completed | Phase 2 | 252 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY |
| 0 |
| Feb 1, 2011 |
| clinicaltrials |
| NCT00211133 | A Study to Evaluate the Impact of Maintaining Hemoglobin Levels Using Epoetin Alfa in Patients With Metastatic Breast Cancer Receiving Chemotherapy | completed | Phase 3 | 939 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 0 | Nov 30, 2010 | clinicaltrials |
| NCT01006304 | An Exploratory Study to Assess the Effects of JNJ-39439335 on the Relief of Pain Using a Thermal-Grill Experimental Model | completed | Phase 1 | 12 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 0 | Jul 2, 2010 | clinicaltrials |
| NCT00048503 | Study of Tipifarnib as Postconsolidation Therapy for Acute Myeloid Leukemia in Patients 60 Years and Older | completed | Phase 2 | 88 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 0 | Apr 27, 2010 | clinicaltrials |
| NCT00653952 | CAELYX Versus Paclitaxel HCl in Patients With Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy | terminated | Phase 3 | 220 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 0 | Apr 27, 2010 | clinicaltrials |
| NCT00677001 | A Research Study to Evaluate the Safety of R306465, a Drug in Development for Cancer and to Study the Absorption, Break Down and Elimination in Patients With Advanced Solid Malignancies. | completed | Phase 1 | 15 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 0 | Apr 27, 2010 | clinicaltrials |
| NCT00676299 | A Safety and Dose-finding Study of JNJ-26483327, a Drug in Development for Cancer, for Patients With Advanced and/or Refractory Solid Malignancies. | completed | Phase 1 | 19 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 0 | Apr 26, 2010 | clinicaltrials |
| NCT00676910 | A Research Study of JNJ-26854165 to Determine the Safety and Dose in Patients With Advanced Stage or Refractory Solid Tumors. | completed | Phase 1 | 71 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 0 | Mar 26, 2010 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials